Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Loupy

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Journal of the American Society of Nephrology : JASN|August 22, 2015
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated InjuryCarmen Lefaucheur, Denis Viglietti, Carol Bentlejewski, et al.
Transplantation|September 23, 2016
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational StudyElisabeth Cassuto, Georges P Pageaux, Diego Cantarovich, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney TransplantationMaarten Naesens, Alexandre Loupy, Luuk Hilbrands, et al.
Clinical Transplantation|November 14, 2022
Outcomes in kidney transplant recipients treated with immediate-release tacrolimus capsules versus extended-release tacrolimus capsules: A cohort studyYoonhee P Ha, Gillian Divard, Nandita Mitra, et al.
BMC Nephrology|October 18, 2024
Successful prevention of BK-polyomavirus nephropathy using extracorporeal photopheresis for immunosuppression minimisation following severe BK polyomavirus replication after kidney transplantation in a double lung transplant recipient, a case reportFlorent Von Tokarski, François Parquin, Antoine Roux, et al.
Transplantation|February 24, 2007
Impact of surgical procedures and complications on outcomes of third and subsequent kidney transplantsAlexandre Loupy, Dany Anglicheau, Marc Olivier Timsit, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Surrogate Endpoints for Late Kidney Transplantation FailureMaarten Naesens, Klemens Budde, Luuk Hilbrands, et al.
Journal of the American Society of Nephrology : JASN|April 16, 2011
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantationGary S Hill, Dominique Nochy, Patrick Bruneval, et al.
Transplantation|April 14, 2010
Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot studyAlexandre Loupy, Caroline Suberbielle-Boissel, Julien Zuber, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Journal of the American Society of Nephrology : JASN|August 22, 2015
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated InjuryCarmen Lefaucheur, Denis Viglietti, Carol Bentlejewski, et al.
Transplantation|September 23, 2016
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational StudyElisabeth Cassuto, Georges P Pageaux, Diego Cantarovich, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney TransplantationMaarten Naesens, Alexandre Loupy, Luuk Hilbrands, et al.
Clinical Transplantation|November 14, 2022
Outcomes in kidney transplant recipients treated with immediate-release tacrolimus capsules versus extended-release tacrolimus capsules: A cohort studyYoonhee P Ha, Gillian Divard, Nandita Mitra, et al.
BMC Nephrology|October 18, 2024
Successful prevention of BK-polyomavirus nephropathy using extracorporeal photopheresis for immunosuppression minimisation following severe BK polyomavirus replication after kidney transplantation in a double lung transplant recipient, a case reportFlorent Von Tokarski, François Parquin, Antoine Roux, et al.
Transplantation|February 24, 2007
Impact of surgical procedures and complications on outcomes of third and subsequent kidney transplantsAlexandre Loupy, Dany Anglicheau, Marc Olivier Timsit, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Surrogate Endpoints for Late Kidney Transplantation FailureMaarten Naesens, Klemens Budde, Luuk Hilbrands, et al.
Journal of the American Society of Nephrology : JASN|April 16, 2011
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantationGary S Hill, Dominique Nochy, Patrick Bruneval, et al.
Transplantation|April 14, 2010
Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot studyAlexandre Loupy, Caroline Suberbielle-Boissel, Julien Zuber, et al.
Pageof 21